title: Is quantitative real time polymerase chain reaction MCAM transcript assay really suitable for prognostic and predictive management of melanoma patients?
authors.affiliation: Laboratory of Clinical Molecular and Personalized Diagnostics, Policlinico A. Gemelli, Teaching Hospital, Largo F. Vito 1, 00136, Rome, Italy; Laboratory of Clinical Molecular and Personalized Diagnostics, Department of Biochemistry and Clinical Biochemistry, Catholic University, Rome, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Capoluongo
authors.forename: C
authors.initials: C
authors.lastname: Paolillo
authors.forename: F
authors.initials: F
authors.lastname: Vendittelli
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000473:pathology*; D009364:Neoplasm Recurrence, Local / Q000473:pathology*; D009360:Neoplastic Cells, Circulating / Q000473:pathology*; D012878:Skin Neoplasms / Q000473:pathology*
chemical_list: D014408:Biomarkers, Tumor